We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
(-15%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-19.45%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$23.2M |
| 2 |
PepsiCo
PEP
|
+$13.1M |
| 3 |
AbbVie
ABBV
|
+$10.1M |
| 4 |
Elevance Health
ELV
|
+$9.59M |
| 5 |
Abbott
ABT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22.4M |
| 2 |
Pfizer
PFE
|
+$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.1M |
| 4 |
Pediatrix Medical
MD
|
+$11.2M |
| 5 |
Danaher
DHR
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.68% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Industrials | 7.26% |
| 4 | Consumer Staples | 5.08% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Clean Harbors
CLH
$16.8B
| $1.34M | 0.19% |
+25,000
| New | +$1.4M |
|
152
Revvity
RVTY
$12.7B
| $1.32M | 0.19% |
+25,000
| New | +$1.3M |
|
153
Walmart Inc
WMT
$884B
| $1.31M | 0.19% |
+55,242
| New | +$1.41M |
|
154
Compass Minerals
CMP
$1.25B
| $1.21M | 0.17% |
14,683
-10,136
| -41% | -$893K |
|
155
Occidental Petroleum
OXY
$55.6B
| $1.19M | 0.17% |
+15,340
| New | +$1.2M |
|
156
Ultragenyx Pharmaceutical
RARE
$2.56B
| $1.19M | 0.17% |
+11,571
| New | +$898K |
|
157
CSX Corp
CSX
$93B
| $1.16M | 0.17% |
+106,701
| New | +$1.24M |
|
158
CALL
Agilent Technologies
A
$39.2B
| $1.16M | 0.17% |
+30,000
| New | +$1.25M |
|
|
VGR
159
DELISTED
Vector Group Ltd.
VGR
| $1.16M | 0.17% |
88,641
-60,951
| -41% | -$758K |
|
160
Ventas
VTR
$44.7B
| $1.15M | 0.17% |
+16,242
| New | +$1.27M |
|
|
NAV
161
CALL
DELISTED
Navistar International
NAV
| $1.13M | 0.16% |
+50,000
| New | +$1.37M |
|
|
VSI
162
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.12M | 0.16% |
+30,000
| New | +$1.2M |
|
|
HDS
163
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.12M | 0.16% |
31,751
-24,875
| -44% | -$827K |
|
164
Korn Ferry
KFY
$4.18B
| $1.08M | 0.16% |
+31,181
| New | +$1.03M |
|
165
Expeditors International
EXPD
$21.8B
| $1.08M | 0.16% |
+23,446
| New | +$1.1M |
|
|
CHUY
166
PUT
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.07M | 0.15% |
+40,000
| New | +$1.02M |
|
|
MBLY
167
DELISTED
Mobileye N.V.
MBLY
| $1.04M | 0.15% |
+19,513
| New | +$925K |
|
168
CALL
Steel Dynamics
STLD
$36.2B
| $1.04M | 0.15% |
+50,000
| New | +$1.08M |
|
|
CERN
169
DELISTED
Cerner Corp
CERN
| $1.04M | 0.15% |
+15,000
| New | +$1.05M |
|
170
CALL
Owens Corning
OC
$11.2B
| $1.03M | 0.15% |
+25,000
| New | +$1.02M |
|
171
Graphic Packaging
GPK
$3.24B
| $1.03M | 0.15% |
+73,682
| New | +$1.06M |
|
172
CALL
NVIDIA
NVDA
$4.72T
| $1.01M | 0.14% |
+2,000,000
| New | +$1.08M |
|
|
CBI
173
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $1M | 0.14% |
20,000
-30,000
| -60% | -$1.56M |
|
|
UAM
174
DELISTED
Universal American Corp
UAM
| $990K | 0.14% |
97,781
+5,000
| +5% | +$52.1K |
|
175
PUT
Freeport-McMoran
FCX
$91.2B
| $931K | 0.13% |
50,000
-50,000
| -50% | -$1.03M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.
- Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
- Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
- Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
- Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
- Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
- Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
- Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.
Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.